Medicare patients with chronic disease remain in desperate need of real cost relief
August 09, 2022 08:50 AM Eastern Daylight Time
WASHINGTON - The Partnership to Fight Chronic Disease (PFCD) released the following statement today in response to the
July 6, 2022 (Washington, D.C.) The Partnership to Fight Chronic Disease (PFCD) released the following statement today regarding the Prescription Drug Pricing Reform proposal aiming to lower drug prices through government negotiation under Medicare:
“More than half of U.S. adults are
Findings Published in Health Affairs Forefront
Precedent-setting policies to restrict access to accelerated approval drugs do not reduce health care spending but rather harm America’s most vulnerable patients
June 3, 2022 (WASHINGTON, D.C.) The Partnership to Fight
CMS decision harms current and future treatment options for Alzheimer's and other chronic disease populations
April 8, 2022 (Washington, D.C.) The Partnership to Fight Chronic Disease (PFCD) released the following statement from Chair Ken Thorpe regarding the Centers for Medicare and
March 01, 2022
Real Clear Policy
By Kenneth E. Thorpe
While the pandemic is by no means over, Covid-19 isn't the only threat to public health we face. In fact, it might not even be our most serious challenge.
Despite the tragic loss of more than 2,000 American
By Kenneth E. Thorpe
February 3, 2022
More than half of Oregon's population -- nearly 2.3 million people -- is living with at least one chronic disease. A disproportionate share rely on Medicaid to provide them the medications they need, and are beneficiaries because of
WASHINGTON (December 7, 2021) -- Today, the Partnership to Fight Chronic Disease (PFCD) released the following statement following President Biden’s remarks on the costs of prescription drugs.
“Especially as Americans are still very much navigating a path forward from
WASHINGTON, D.C. (November 3, 2021) Today, the Partnership to Fight Chronic Disease (PFCD) released the following statement on the drug pricing plan that Congress is considering.
“While we wait to see the details of this plan, Senate negotiators have apparently taken some
By Kenneth Thorpe
10/24/21 AT 6:30 AM
Beating Covid-19 has certainly taken longer than most of us were hoping, but we've turned the corner, and it's never too early to begin the critical exercise of assessing "lessons learned."
Clearly, in numerous
BY PAT FURLONG , ANNIE KENNEDY & KEN THORPE
October 20, 2021 at 5:00 am ET
Today, you can go from hero to villain instantaneously. The Food and Drug Administration was rightfully applauded for efficiently reviewing COVID-19